Novavax grabs another CFO while Pat Cotroneo retires from FibroGen; Eli Lilly reassembles key staff after biomedicines unit split

Jim Kelly

→ The perennial Charlie Brown of vaccine development, Novavax is grappling with Lucy’s knack for pulling the football away once again, this time with its Covid-19 vaccine as the FDA pushed back another bid for an EUA earlier this month. In the meantime,...

Click to view original post